Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


Last --
Change Today 0.00 / 0.00%
Volume 0.0
3401 On Other Exchanges
Symbol
Exchange
3401 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

teijin ltd (3401) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TEIJIN LTD (3401)

Related News

No related news articles were found.

teijin ltd (3401) Related Businessweek News

No Related Businessweek News Found

teijin ltd (3401) Details

Teijin Limited provides solutions to transportation, information and electronics, safety and protection, environment and energy, and healthcare areas worldwide. The company’s Advanced Fibers and Composites segment offers para-aramid, meta-aramid, polyester, and polyethylene naphthalate (PEN) fibers; synthetic leather; carbon fibers and intermediate materials; carbon fiber reinforced composites; and flame-resistant fibers. Its Electronics Materials and Performance Polymer Products segment provides polycarbonate (PC) resins, PC/ABS and PC/AS polymer alloys, PEN resins, polyethylene terephthalate (PET) resins, polybutylene naphthalete resins, bromine series flame retardants, PET and PEN films, processed films, monomers, and polymers. The company’s Healthcare segment offers Bonalon and Onealfa for the treatment of osteoporosis; Synvisc to treat knee osteoarthritis pain; sonic accelerated fracture healing systems; Mucosolvan, an expectorant; and Alvesco, an inhaled corticosteroid agent for asthma. This segment also provides oxygen concentrators for home oxygen therapy; continuous positive airway pressure units; NIP NASAL, a non-invasive positive pressure ventilator; AutoSet CS, an adaptive servo-ventilator; Feburic to treat hyperuricemia and gout; Tricor for hyperlipidemia; and Venilon for Intravenous immunoglobulin preparation. Its Trading and Retail segment sells and trades fibrous raw material, apparel, industrial materials, and performance polymer products. The company also offers IT services in the healthcare field, Web-based enterprise resource planning, and digital content management services; content distribution services for mobile phones and smartphones, and e-commerce services; and polyester raw materials and polymerization services. Teijin Limited was founded in 1918 and is headquartered in Osaka, Japan.

15,780 Employees
Last Reported Date: 06/24/15
Founded in 1918

teijin ltd (3401) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

teijin ltd (3401) Key Developments

Teijin Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2016; Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2015; Revises Earnings Guidance for the Fiscal Year Ending March 31, 2016

Teijin Ltd. provided year-end dividend forecast for the fiscal year ending March 31, 2016 of JPY 4.00 per share compared to JPY 2.00 per share declared a year ago. The company announced consolidated earnings results for the third quarter and nine months ended December 31, 2015. For the quarter, the company reported net sales of JPY 199.2 billion compared with JPY 201.1 billion for the same period a year ago. Operating income was JPY 20.1 billion compared with JPY 12.4 billion for the same period a year ago. Ordinary income was JPY 21.0 billion compared with JPY 14.9 billion for the same period a year ago. Profit attributable to owners of parent was JPY 10.5 billion compared with JPY 7.9 billion for the same period a year ago. For the nine months, the company reported net sales of JPY 591,293 million compared with JPY 578,450 million for the same period a year ago. Operating income was JPY 55,488 million compared with JPY 24,568 million for the same period a year ago. Ordinary income was JPY 56,808 million compared with JPY 28,961 million for the same period a year ago. Profit attributable to owners of parent was JPY 34,922 million or JPY 32.24 per diluted share compared with loss attributable to owners of parent of JPY 14,424 million or JPY 14.68 per share for the same period a year ago. Income before income taxes was JPY 46,204 million compared with loss before income taxes of JPY 17,150 million for the same period a year ago. Total capital expenditure was JPY 22 billion. For the year ending March 31, 2016, the company expects net sales of JPY 790,000 million, operating income of JPY 65,000 million, ordinary income of JPY 65,000 million and profit attributable to owners of parent of JPY 37,000 million or JPY 37.64 per share compared to previous guidance of net sales of JPY 790,000 million, operating income of JPY 58 billion, ordinary income of JPY 58 billion and profit attributable to owners of parent of JPY 34 billion. Total capital expenditure is expected to be JPY 40.0 billion.

Teijin Ltd., Q3 2016 Earnings Call, Feb 01, 2016

Teijin Ltd., Q3 2016 Earnings Call, Feb 01, 2016

Teijin Ltd. to Report Q3, 2016 Results on Feb 01, 2016

Teijin Ltd. announced that they will report Q3, 2016 results on Feb 01, 2016

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
3401:JP ¥354.00 JPY -16.00

3401 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Celanese Corp $56.62 USD -0.32
LANXESS AG €33.78 EUR -0.66
Mitsui Chemicals Inc ¥397.00 JPY -18.00
Trinseo SA $22.98 USD -0.78
View Industry Companies
 

Industry Analysis

3401

Industry Average

Valuation 3401 Industry Range
Price/Earnings 9.5x
Price/Sales 0.5x
Price/Book 1.1x
Price/Cash Flow 7.6x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TEIJIN LTD, please visit www.teijin.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.